Shared on 03 Nov 25
Fair value Increased 0.90%Analysts have raised their price target for IHH Healthcare Berhad slightly, from RM8.45 to RM8.52. This reflects modest adjustments in their fair value assessments and expectations for profitability.
Shared on 20 Oct 25
Fair value Increased 0.31%Analysts have slightly raised their price target for IHH Healthcare Berhad from RM8.42 to RM8.45, citing continued confidence in the company's financial metrics and stability. What's in the News IHH Healthcare Berhad announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).
Shared on 06 Oct 25
Fair value Increased 2.17%Analysts have raised their price target for IHH Healthcare Berhad from RM8.24 to RM8.42, with modest improvements in revenue growth forecasts cited as the primary driver for the adjustment. What's in the News IHH Healthcare Berhad has announced an interim single tier cash dividend of RMB 0.050 per ordinary share for the financial year ending 31 December 2025 (Key Developments).
Shared on 23 Apr 25
Fair value Decreased 0.12%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 1.33%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Increased 0.12%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 0.49%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 0.42%AnalystConsensusTarget has increased revenue growth from 7.2% to 8.8%, decreased profit margin from 12.0% to 8.7% and decreased future PE multiple from 41.4x to 33.9x.